G

Genovefa A. Papanicolaou

Memorial Sloan Kettering Cancer Center

ORCID: 0000-0002-2891-079X

286 papers and 11.6k citations.

PubIndex Score97Top 3%How it's scored

286Publications

11.6kTotal Citations

First publication: 1990First senior author: 1991

Top publicationsby citations

Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial

Robin K. Avery, Francisco M. Marty, Genovefa A. Papanicolaou et al.|Clinical Infectious Diseases|2021

Cited by 299

A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients

Edward A. Stadtmauer, Elchonon M. Berkowitz, Keith M. Sullivan et al.|Blood|2014

Cited by 177

Best Practice Considerations by The American Society of Transplant and Cellular Therapy: Infection Prevention and Management After Chimeric Antigen Receptor T Cell Therapy for Hematological Malignancies

Zainab Shahid, Joshua A. Hill, Tania Jain et al.|Transplantation and Cellular Therapy|2024

Cited by 78

Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients

Sunwen Chou, Martha Fournier, Sophie Alain et al.|The Journal of Infectious Diseases|2023

Cited by 77

Guidelines for COVID-19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients

Alpana Waghmare, Zainab Shahid, Maheen Z. Abidi et al.|Biology of Blood and Marrow Transplantation|2020

Cited by 65

Indexing the rest of 286 publications…